Example: biology
WORLD ANTI-DOPING CODE PROHIBITED LIST
3 Introduction The Prohibited List is a mandatory International Standard as part of the World Anti-Doping Program. The List is updated annually following an extensive consultation process facilitated by WADA.The effective date of the List is 01 January 2021. The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French.
Information
Domain:
Source:
Link to this page:
Documents from same domain
MINUTES - WADA FINANCE AND ADMINISTRATION …
www.wada-ama.org1 / 3 MINUTES - WADA FINANCE AND ADMINISTRATION COMMITTEE MEETING HELD IN LAUSANNE ON 22 AUGUST 2007 PRESENT: Craig Reedie, Chairman Patrick Chamunda Robert De …
SUMMARY OF MAJOR MODIFICATIONS AND EXPLANATORY …
www.wada-ama.org3 Substances Prohibited in Particular Sports BETA-BLOCKERS • Bunolol is a racemic mixture of levobunolol and bunolol, so levobunolol was removed as an example in P1.
WORLD ANTI-DOPING CODE - wada-ama.org
www.wada-ama.orgWorld Anti-Doping Code The World Anti-Doping Code was first adopted in 2003, took effect in 2004, and was then amended effective 1 January 2009.
PROHIBITED LIST - World Anti-Doping Agency
www.wada-ama.orgTHE WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST JANUARY 2018 The official text of the Prohibited List shall be maintained by WADA and shall be published in …
WORLD ANTI-DOPING CODE PROHIBITED LIST
www.wada-ama.org3 Introduction The Prohibited List is a mandatory International Standard as part of the World Anti-Doping Program. The List is updated annually following an extensive consultation process facilitated by WADA.The effective date of the List is 01 January 2021. The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French.
World Anti-Doping
www.wada-ama.orgJan 24, 2012 · PART ONE DOPING CONTROL ... 14.2 NOTICE OF ANTI-DOPING RULE VIOLATION OR ... that robust rules and sanctions are in place and salient for all stakeholders. Detection — an effective Testing and investigations system not only enhances a deterrent effect, but also is effective in
83 - World Anti-Doping Agency
www.wada-ama.orgISTI – January 2021 Page 2 of 83. International Standard for Testing and Investigations . The World Anti-Doping Code International Standard for Testing and Investigations is a mandatory International Standard developed as part of the World Anti -Doping Program. It was developed in consultation with Signatories, public authorities, and other relevant stakeholders.
1 of 56
www.wada-ama.orgPART ONE: INTRODUCTION, CODE PROVISIONS, INTERNATIONAL STANDARD PROVISIONS AND DEFINITIONS 1.0 Introduction and Scope The International Standardfor Results Management is a mandatory International Standard developed as part of the World Anti -Doping Program. The purpose of the International Standardfor Results Management is to set …
WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD …
www.wada-ama.org• Vascular endothelial growth factor (VEGF) and other growth factors or growth factor modulators affecting muscle, tendon or ligament protein synthesis/degradation, vascularisation, energy utilization, regenerative capacity or fibre type switching. 3. GROWTH FACTORS AND GROWTH FACTOR MODULATORS S2 PEPTIDE HORMONES, GROWTH FACTORS, …
WORLD ANTI-DOPING CODE
www.wada-ama.orgInternational Standards International Standards for different technical and operational areas within the anti-doping program have been and will be developed in consultation with the Signatories and governments and approved by WADA. The purpose of the International Standards is harmonization among Anti-Doping Organizations responsible for
Related documents
Long-term Consequences of Polycystic Ovary Syndrome
www.rcog.org.ukClinical features of hyperandrogenism include hirsutism characterised by excess facial and body hair and midline hair growth. Although free and total testosterone is used in the diagnosis of PCOS, the recommended baseline biochemical test for hyperandrogenism is …
Osteoporosis Screening, Diagnosis, and Treatment Guideline ...
wa.kaiserpermanente.org• Androgen deprivation therapy • Anti-epileptics (e.g., phenytoin, phenobarbital) • Excess thyroid replacement • GnRH agonists (e.g., Lupron) • Depo-Provera (medroxyprogesterone acetate) 6 ; Treatment Overview ; Table 3. Recommendations for treatment of …
Osteoporosis risk assessment, diagnosis and management
www.racgp.org.au» Excess thyroid hormone replacement » Aromatase inhibitors » Anti-androgen therapy† Medications (modest effect) » SSRIs » Anti-psychotics » Thiazolidenediones Anti-epileptic medications PPIs T-score ≤–1.5 T-score >–1.5 No Yes Where appropriate » Implement falls reduction strategies (Grade A)
Hormon-hormon yang berperan pada proses metabolisme
repository.ui.ac.idExcess ↓ TSH, TBG, TTR, T3, T4, ↑rT3 Deficiency ↑ TSH Estrogen ↑ TBG sialylation & serum t1/2 ↑ T4 requirement in hypothyroidism ↑ TSH in postmenopausal women Androgen ↓ TBG ↓ T4 turnover in women ↓ T4 requirement in hypothyroidism
2022 Prohibited List - wada-ama.org
www.wada-ama.org• Tibolone is transferred from S1.2 to S1.1 because it has clinical effects as a synthetic oral androgen mediated by effects on the androgen receptor, largely due to its conversion to the delta-4 tibolone metabolite, which is a potent androgen. • Osilodrostat, a CYP11B1 inhibitor, is added to S1.2 due to its off-target increase in circulating
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu(mHSPC) in adult men in combination with androgen deprivation therapy (ADT) (see section 5.1) the treatment of metastatic castration resistant prostate cancer (mCRPC) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section5.1)
NCCN Clinical Practice Guidelines in Oncology (NCCN ...
www2.tri-kobe.orgPrinciples of Androgen Deprivation Therapy (PROS-F) Principles of Immunotherapy and Chemotherapy (PROS-G) Staging (ST-1) The NCCN Guidelines® are a statement of evidence and consensus of the authors regarding their views …
Hospital treatment protocol for covid-19
covid19criticalcare.comDual Anti-Androgen therapy Hospitalized patients 1. Spironolactone 100mg twice daily 2. Dutasteride 2mg on day 1, followed by 1mg daily — or Finasteride 10 mg daily 14 days or until discharge from hospital ICU Patients 1. Flutamide 250 mg TID — or Bicalutamide 150 mg daily 2. Dutasteride 2 mg on day 1, followed by 1 mg daily —